Research and Development

Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …

The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …

The FDA has approved Amgen’s Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukaemia (B-cell ALL). …

IDEA Pharma has hired both Samantha Weston and Paul Kelly as vice presidents in business development to boost the company’s …

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …

GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …

Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …

Patients are still pointlessly dying of lung cancer due to a ‘postcode lottery’ of services according to new results from …

The European Medicines Agency has confirmed that Andreas Pott will remain in charge of the body in place of the …

The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …

Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into …

The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …

Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors.  Paoletti has been …